Accuray (ARAY) Common Equity (2011 - 2026)
Accuray's (ARAY) quarterly Common Equity came in at $41.7 million in Q1 2026, down 15.88% year-on-year from $49.6 million in Q1 2025, and down 21.93% quarter-over-quarter from $53.4 million in Q4 2025.
Accuray (ARAY) Common Equity (2011 - 2026) Analysis & Trends
Accuray's Common Equity history runs 16 years deep, the most recent figure standing at $41.7 million for Q1 2026.
- On a quarterly basis, Common Equity fell 15.88% year-over-year to $41.7 million in Q1 2026; TTM through Mar 2026 was $41.7 million, a 15.88% decrease from a year earlier, with the FY2025 full-year figure at $81.2 million, up 80.04% from the prior year.
- Common Equity eased to $41.7 million in Q1 2026 per ARAY's latest filing, from $53.4 million in the prior quarter.
- Across five years, Common Equity topped out at $81.2 million in Q2 2025 and bottomed at $30.6 million in Q1 2022.
- The 5-year median for Common Equity is $47.9 million (2024), against an average of $48.8 million.
- Across the five-year window, Common Equity declined 22.74% in 2022 and surged 80.04% in 2025, its largest moves.
- Year by year, Common Equity stood at $51.7 million in 2022, then dropped by 7.91% to $47.7 million in 2023, then gained by 0.5% to $47.9 million in 2024, then rose by 11.54% to $53.4 million in 2025, then declined by 21.93% to $41.7 million in 2026.
- Per Business Quant, the three latest ARAY Common Equity figures stand at $41.7 million (Q1 2026), $53.4 million (Q4 2025), and $61.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 52.70 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 38.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 25.86 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.96 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 13.34 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.67 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.29 Bn |
| 10 | Accuray | 29,832.96 | -38.50 Mn | 25.29 Mn | 41.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 41.71 Mn |
| Dec 31, 2025 | 53.42 Mn |
| Sep 30, 2025 | 61.87 Mn |
| Jun 30, 2025 | 81.17 Mn |
| Mar 31, 2025 | 49.58 Mn |
| Dec 31, 2024 | 47.89 Mn |
| Sep 30, 2024 | 45.22 Mn |
| Jun 30, 2024 | 45.08 Mn |
| Mar 31, 2024 | 35.51 Mn |
| Dec 31, 2023 | 47.65 Mn |
| Sep 30, 2023 | 50.94 Mn |
| Jun 30, 2023 | 53.66 Mn |
| Mar 31, 2023 | 33.58 Mn |
| Dec 31, 2022 | 51.75 Mn |
| Sep 30, 2022 | 46.99 Mn |
| Jun 30, 2022 | 53.19 Mn |
| Mar 31, 2022 | 30.55 Mn |
| Dec 31, 2021 | 50.99 Mn |
| Sep 30, 2021 | 45.77 Mn |
| Jun 30, 2021 | 68.84 Mn |